INTRANASAL COLLOIDAL DRUG DELIVERY SYSTEM FOR BRAIN TARGETING OF DRUGS
Loading...
Date
item.page.authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
prevents the effective concentration at the brain due to
newlinepresence of biological barriers and extensive first pass metabolism (9% and 36%
newlinerespectively) and thus resulting into frequent dosing. The aim of the investigation
newlinewas to develop intranasal microemulsion and mucoadhesive microemulsion system
newlineof the quetiapine and rivastigmine to overcome the limitation of poor concentration
newlineand obstructive barriers at the target site for improved bioavailability. Optimized
newlineformulations of quetiapine and rivastigmine were characterized for various
newlinephysicochemical and diffusion parameters. It was found that chitosan based
newlinemucoadhesive microemulsion showed improved nasal diffusion for both the drugs in
newlinecomparison to microemulsion and drug solution as a result of enhanced paracellular
newlinetransport across nasal mucosa. In vitro cell line study demonstrated that chitosan
newlinebased microemulsion system induced reversible opening of tight junctions and hence
newlineshowed higher diffusion for quetiapine via paracellular route. Spray pattern and
newlineplume geometry data showed satisfactory results with plume length in the range of
newline10-12 cm, thus confirming the delivery of formulation into posterior nasal segment
newlineand hence enhanced delivery to brain via olfactory route. In vivo pharmacokinetic
newlinestudy demonstrated superior nasal bioavailability for both the drugs with chitosan
newlinebased mucoadhesive microemulsion against individual drug solution, thus revealing
newlinethe potential of chitosan as permeability enhancer and/or tight junction modulator
newlinefor preferential nose to brain transport bypassing blood brain barrier. Results of
newlinegamma scintigraphy study and in vivo pharmacokinetic parameters showed
newlinesatisfactory correlation between pharmacokinetic parameters for intranasally
newlineadministered chitosan loaded microemulsion. Overall, the above findings show
newlinepromising results in the area of developing
newline